NEWS

Kutxa Fundazioa, the Basque Government, and the Spanish Government are driving Oncomatryx’s transformation into a biopharmaceutical company

by

The Spanish Government is contributing 24.3 million euros through the Ministry of Science, Innovation, and Universities, reinforcing its commitment to technological innovation for health. Kutxa Fundazioa leads the Basque investment with 15 million euros, alongside a 10.5 million euro contribution from the Basque Government and Ekarpen and 2 million euros from BBK, bringing the total … Read more

Oncomatryx receives the Banco Santander and Spanish Chamber of Commerce Innovation Award from the King

by

Banco Santander and the Spanish Chamber of Commerce present the 2025 National SME of the Year Award Thursday, February 19, 2026. Oncomatryx has received the Innovation and Digitalization Award at the 9th edition of the National SME of the Year Awards, organized by Banco Santander and the Spanish Chamber of Commerce. King Felipe VI presented … Read more

A Spanish drug offers new hope to patients with metastatic cancer

by

Laureano Simón, CEO of Oncomatryx, explains on “La Ventana” how this new treatment could reverse metastasis. A Spanish drug offers new hope to patients with metastatic cancer There is still no cure for cancer, but investment in research and technology is making it possible for many cancer patients to enjoy a better quality of life … Read more